Bleakley Financial Group LLC Raises Holdings in Sanofi (NASDAQ:SNY)

Bleakley Financial Group LLC boosted its stake in Sanofi (NASDAQ:SNY) by 12.4% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 108,373 shares of the company’s stock after buying an additional 11,949 shares during the quarter. Bleakley Financial Group LLC’s holdings in Sanofi were worth $5,267,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of SNY. EP Wealth Advisors LLC lifted its stake in shares of Sanofi by 13.4% during the third quarter. EP Wealth Advisors LLC now owns 4,780 shares of the company’s stock valued at $256,000 after buying an additional 563 shares during the period. B. Riley Wealth Advisors Inc. boosted its holdings in shares of Sanofi by 25.5% during the third quarter. B. Riley Wealth Advisors Inc. now owns 20,925 shares of the company’s stock worth $1,122,000 after purchasing an additional 4,257 shares during the last quarter. Anchor Investment Management LLC purchased a new stake in shares of Sanofi in the fourth quarter valued at $154,000. Foundation Resource Management Inc. increased its stake in Sanofi by 1.4% in the fourth quarter. Foundation Resource Management Inc. now owns 269,996 shares of the company’s stock valued at $13,427,000 after purchasing an additional 3,602 shares during the last quarter. Finally, BKM Wealth Management LLC purchased a new position in Sanofi during the fourth quarter worth about $251,000. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Trading Up 0.3 %

SNY traded up $0.16 during midday trading on Wednesday, hitting $50.21. The company’s stock had a trading volume of 1,918,463 shares, compared to its average volume of 2,132,379. Sanofi has a 52-week low of $42.63 and a 52-week high of $55.72. The firm has a 50-day moving average price of $48.91 and a two-hundred day moving average price of $48.66. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. The firm has a market cap of $127.17 billion, a P/E ratio of 25.28, a PEG ratio of 1.55 and a beta of 0.59.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The business had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. On average, research analysts anticipate that Sanofi will post 4.14 earnings per share for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.